| Financial Year |
March 31 2023 |
| Monetary Funds |
1,280,393,856.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
383,824,127.95 |
| Advances to Suppliers |
199,821,630.93 |
| Other Receivables |
4,685,122.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,565,661,027.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,822,813.36 |
| Total Current Assets |
3,566,241,934.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,505,641.59 |
| Investment Properties |
-- |
| Fixed Assetes |
3,129,104,350.70 |
| Under-construction Projects |
3,297,482,236.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
246,309,200.15 |
| R&D expenses |
-- |
| Goodwill |
1,975,281.21 |
| Long-Term Deferred and Prepaid Expenses |
362,393,282.52 |
| Deferred Income Tax Assets |
49,329,337.61 |
| Other Non-Current Assets |
336,573,093.13 |
| Sub-Total of Non-Current Assets |
7,439,672,423.23 |
| Total Assets |
11,005,914,358.18 |
| Short-Term Loans |
2,680,826,873.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
663,838,761.61 |
| Accounts Payable |
975,560,098.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,603,140.93 |
| Taxes Payable |
4,975,242.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,091,108.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
339,884,838.17 |
| Other Current Liabilities |
7,057,195.14 |
| Sub-Total of Current Liabilities |
4,762,761,310.77 |
| Long-term Loans |
1,637,463,009.28 |
| Bonds Payable |
759,111,180.12 |
| Long-Term Accounts Payable |
869,423,828.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,792,464.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,310,479,373.43 |
| Total Liabilities |
8,073,240,684.20 |
| Paid-In Capital(Or Share Stock) |
593,165,169.00 |
| Capital Surplus |
823,065,610.02 |
| Surplus Reserve |
88,648,499.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
597,160,370.15 |
| Minority Stockholder's Interest |
608,443,085.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,324,230,588.47 |
| Owner's Equity（Stockholder's Equity） |
2,932,673,673.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,005,914,358.18 |
